Detalhe da pesquisa
1.
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial.
Lancet Oncol
; 22(2): 267-276, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33539744
2.
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Int J Gynecol Cancer
; 31(6): 875-882, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33931498
3.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Int J Gynecol Cancer
; 31(10): 1348-1355, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34462317
4.
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer.
Expert Opin Emerg Drugs
; 25(4): 445-453, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33040627
5.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31029508
6.
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Gynecol Oncol
; 153(3): 535-540, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30979589
7.
Pembrolizumab in lung cancer: current evidence and future perspectives.
Future Oncol
; 15(29): 3327-3336, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31432705
8.
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.
Support Care Cancer
; 27(9): 3531-3535, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-30684048
9.
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
Gynecol Oncol
; 144(2): 256-259, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27993479
10.
Angiogenesis Inhibitors in NSCLC.
Int J Mol Sci
; 18(10)2017 Sep 21.
Artigo
Inglês
| MEDLINE | ID: mdl-28934120
11.
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
BMC Cancer
; 16: 69, 2016 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26857924
12.
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 16(5): 561-8, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25882986
13.
Past, present and future use of cytotoxic agents in oncology practice: A systematic review of Pubmed and ClinicalTrials.gov databases.
J Oncol Pharm Pract
; 26(8): 2069-2072, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32819200
14.
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).
BMC Cancer
; 14: 875, 2014 Nov 24.
Artigo
Inglês
| MEDLINE | ID: mdl-25421252
15.
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients.
Curr Oncol
; 30(2): 2501-2509, 2023 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36826152
16.
Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers.
Explor Target Antitumor Ther
; 4(4): 716-726, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37711591
17.
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysis.
EClinicalMedicine
; 56: 101824, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36713467
18.
Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis.
Cancer Treat Rev
; 115: 102512, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36774658
19.
Overview of Trop-2 in Cancer: From Pre-Clinical Studies to Future Directions in Clinical Settings.
Cancers (Basel)
; 15(6)2023 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36980630
20.
Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis.
Explor Target Antitumor Ther
; 4(6): 1136-1144, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38213541